0110 GMT - Top Glove Corp.'s earnings outlook seems neutral, Public Investment Bank analyst Thye May Ting says in a note. Projected declines in raw material prices in 1H 2025 may pressure the company to maintain flat or slightly lower pricing to protect market share. However, higher sales volumes, spurred by a potential U.S. tariff hike on Chinese medical gloves due to take effect in January will likely mitigate some of that pressure, she says. Top Glove's production capacity is on track to increase 6.7% to 64 billion pieces annually, she adds. Public IB maintains a neutral rating on Top Glove with a MYR1.20 target. Shares are 3.0% higher at MYR1.36. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
December 22, 2024 20:13 ET (01:13 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。